Latest News | Zydus Cadila Gets Approval from Mexican Authority to Test COVID-19 Drug
Get latest articles and stories on Latest News at LatestLY. Drug firm Zydus Cadila on Monday said it has received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Desidustat in the management of COVID-19.
New Delhi, Jul 6 (PTI) Drug firm Zydus Cadila on Monday said it has received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Desidustat in the management of COVID-19.
"Clinical and regulatory development of Desidustat in COVID-19 is being executed in Mexico by Avant Santé Research Center S.A. de C.V., a leading contract research organisation headquartered in Monterrey, Mexico," Cadila Healthcare said in a regulatory filing.
Also Read | Motorola One Fusion+ Online India Sale Today at 12 Noon via Flipkart, Check Prices & Offers.
The company said it will conduct a study to evaluate the efficacy and safety of Desidustat tablets for the management of COVID-19 patients.
"As a part of the study, 100 mg tablets of Desidustat will be administered for a period of 14 days along with recommended standard care during the trial," the company added.
Also Read | On Sylvester Stallone's Birthday, Talking About 5 of His Most Entertaining Movies.
Zydus Cadila Chairman Pankaj R Patel said, “At Zydus, we have been stepping up our efforts to fight the COVID-19 pandemic through therapeutic drugs, diagnostics and vaccines. With Desidustat we will study a novel approach for management of COVID-19".
Zydus had initiated two phase-III trials of Desidustat.
Last week, Zydus had received approval from Indian authorities to start human trials for its COVID-19 vaccine contender - the second Indian pharmaceutical firm to get such nod amid a surge in novel coronavirus infections worldwide.
Shares of Cadila Healthcare, the listed entity of the group, were trading at Rs 363.40 apiece on BSE, 0.78 per cent lower against their previous close.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)